These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25699389)

  • 1. A randomized control study to investigate the application of Ulinastatin-containing contrast medium to prevent post-ERCP pancreatitis.
    Wang J; Su J; Lu Y; Zhou H; Gong B
    Hepatogastroenterology; 2014; 61(136):2391-4. PubMed ID: 25699389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
    Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.
    Yoo JW; Ryu JK; Lee SH; Woo SM; Park JK; Yoon WJ; Lee JK; Lee KH; Hwang JH; Kim YT; Yoon YB
    Pancreas; 2008 Nov; 37(4):366-70. PubMed ID: 18953247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
    Tsujino T; Komatsu Y; Isayama H; Hirano K; Sasahira N; Yamamoto N; Toda N; Ito Y; Nakai Y; Tada M; Matsumura M; Yoshida H; Kawabe T; Shiratori Y; Omata M
    Clin Gastroenterol Hepatol; 2005 Apr; 3(4):376-83. PubMed ID: 15822043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
    Chen S; Shi H; Zou X; Luo H
    Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial.
    Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC
    Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.
    Ueki T; Otani K; Kawamoto K; Shimizu A; Fujimura N; Sakaguchi S; Matsui T
    J Gastroenterol; 2007 Feb; 42(2):161-7. PubMed ID: 17351806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
    Tsujino T; Isayama H; Nakai Y; Ito Y; Togawa O; Toda N; Arizumi T; Kogure H; Yamamoto K; Mizuno S; Yashima Y; Yagioka H; Sasaki T; Matsubara S; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
    J Gastroenterol; 2013 Aug; 48(8):982-8. PubMed ID: 23090004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
    Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
    Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproteases in preventing post-ERCP acute pancreatitis.
    Tsujino T; Kawabe T; Omata M
    JOP; 2007 Jul; 8(4 Suppl):509-17. PubMed ID: 17625308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct spraying of shakuyakukanzoto onto the duodenal papilla: a novel method for preventing pancreatitis following endoscopic retrograde cholangiopancreatography.
    Fujinami H; Kajiura S; Ando T; Mihara H; Hosokawa A; Sugiyama T
    Digestion; 2015; 91(1):42-5. PubMed ID: 25632916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New endoscopic treatment for chronic pancreatitis, using contrast media containing ulinastatin and prednisolone.
    Ohwada M; Watanabe N; Maeda M; Gotoh M; Teramoto J; Moriya H; Nakajima T; Okamoto T; Tsuji N; Kobayashi D; Niitsu Y
    J Gastroenterol; 1997 Apr; 32(2):216-21. PubMed ID: 9085171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.
    Milewski J; Rydzewska G; Degowska M; Kierzkiewicz M; Rydzewski A
    World J Gastroenterol; 2006 Jun; 12(23):3751-5. PubMed ID: 16773694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a rapid urine amylase test using post-ERCP hyperamylasemia as a model.
    Hegewald MJ; Isenberg G; Sterling RK; Cooper GS; Chak A; Sivak MV
    Am J Gastroenterol; 2001 Sep; 96(9):2640-5. PubMed ID: 11569688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of trypsinogen-2 levels as an early diagnostic for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Kobayashi K; Sasaki T; Serikawa M; Inoue M; Itsuki H; Chayama K
    Pancreas; 2011 Nov; 40(8):1206-10. PubMed ID: 21792081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
    Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
    Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
    Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of qingyi decoction in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia].
    Liu CG; Leng DY; Liu H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):607-10. PubMed ID: 19852292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.
    Mann DV; Kalu P; Foulds S; Edwards R; Glazer G
    Endoscopy; 2001 May; 33(5):448-53. PubMed ID: 11396766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.